Mavik and Terminal state - a phase IV clinical study of FDA data

Summary:

Terminal state is reported only by a few people who take Mavik.

The phase IV clinical study analyzes which people take Mavik and have Terminal state. It is created by eHealthMe based on reports of 2,901 people who have side effects while taking Mavik from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

2,901 people reported to have side effects when taking Mavik.
Among them, 5 people (0.17%) have Terminal state.


What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 2,975 Mavik users for its effectiveness, alternative drugs and more.

What is Terminal state?

Terminal state (the transitional states between life and biological death) is found to be associated with 817 drugs and 500 conditions by eHealthMe.

Number of Mavik and Terminal state reports submitted per year:

Could Mavik cause Terminal state?

Gender of people who have Terminal state when taking Mavik *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Terminal state when taking Mavik *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Mavik *:

  1. Hydrochlorothiazide: 2 people, 40.00%
  2. Duoneb: 1 person, 20.00%
  3. Coumadin: 1 person, 20.00%
  4. Darvocet: 1 person, 20.00%
  5. Decadron: 1 person, 20.00%
  6. Demadex: 1 person, 20.00%
  7. Demerol: 1 person, 20.00%
  8. Digoxin: 1 person, 20.00%
  9. Diovan: 1 person, 20.00%
  10. Efudex: 1 person, 20.00%

Common side effects people have besides Terminal state *:

  1. Metastases To Liver (cancer spreads to liver): 2 people, 40.00%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 40.00%
  3. Bronchial Carcinoma (lung cancer): 2 people, 40.00%
  4. Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 20.00%
  5. Death: 1 person, 20.00%
  6. Disease Progression: 1 person, 20.00%
  7. Dizziness: 1 person, 20.00%
  8. Drug Dependence: 1 person, 20.00%
  9. Emotional Distress: 1 person, 20.00%
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 20.00%

Common conditions people have *:

  1. Essential Hypertension (primary hypertension): 4 people, 80.00%
  2. Cardiomyopathy (weakening of the heart muscle): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and have Terminal state?

Check whether Terminal state is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Terminal state and when was it recovered:

Expand to all the drugs that have ingredients of trandolapril:

Alternative drugs to, pros and cons of Mavik:

Common Mavik side effects:

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Terminal state treatments and more:

COVID vaccines that are related to Terminal state:

Common drugs associated with Terminal state:

All the drugs that are associated with Terminal state:

Common conditions associated with Terminal state:

All the conditions that are associated with Terminal state:

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril (the active ingredients of Mavik) and Mavik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: